{"id":619557,"title":"ARCHIVED Updated requirements for COVID-19 drug authorizations: Notice - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2026-03-08","captureTimestamp":"2026-03-08T11:12:23.272000+00:00","jobId":6,"originalUrl":"https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/updated-requirements-drug-authorization-notice.html","snippet":"ARCHIVED Updated requirements for COVID-19 drug authorizations: Notice COVID-19 drugs that were authorized in Canada under the Interim order respecting the importation, sale and advertising of drugs for use in relation to COVID-19 (ISAD IO) were able to transition and file a new…","rawSnapshotUrl":"/api/snapshots/raw/619557","browseUrl":"https://replay.healtharchive.ca/job-6/20260308111223/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/updated-requirements-drug-authorization-notice.html#ha_snapshot=619557","mimeType":"text/html","statusCode":200}